Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel
Uitgebreid zoeken

Onward 2025: Stock Lift-Up

838 Posts
Pagina: «« 1 ... 37 38 39 40 41 42 »» | Laatste | Omlaag ↓
  2. forum rang 4 nb 13 maart 2025 15:15

    • nb

      Lid sinds: 09 sep 2009

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 641

      Gegeven: 144

    •    Aantal posts: 3.797

    Ik heb wel een beetje hoop dat dit de bodem zo ongeveer is. Ben niet zo vd technische analyse, dus corrigeer me maar zo nodig, maar leg je de lat over de laatste 3 jaar, dan is de bodem zo rond 4.75. Daarna veert het steeds weer op. Valt natuurlijk tegen dat het geen hogere bodems aan kan.
    Als het maar geen Avantium wordt, veel goed nieuws, steeds lagere koersen
  4. forum rang 4 nb 13 maart 2025 16:39

    • nb

      Lid sinds: 09 sep 2009

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 641

      Gegeven: 144

    •    Aantal posts: 3.797

    Dat durf ik nog niet, % gewijs heb ik al iets teveel. Wacht even de ontwikkelingen af. Maar de vingers jeuken wel
  6. forum rang 4 HOBBYMAN 13 maart 2025 17:44

    • HOBBYMAN

      Lid sinds: 22 feb 2019

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 691

      Gegeven: 36

    •    Aantal posts: 1.348

    Shit! Gisteren toch nog te vroeg gekocht. Het is voor mij duidelijk dat. 1 partij de koers omlaag dirigeert in opdracht van ???
    Het is voor deze partij erg makkelijk bij zulke magere handel in dit aandeel. Elke dag ongeveer 10 cent eraf zet uiteindelijk toch zoden aan de dijk.
    Ik had moeten wachten tot koers op €4,50 staat zoals ik eerder van plan was.
    Maar ja, hebzucht en bang om boot te missen zijn slechte raadgevers.
    Ik wacht maar op goed nieuws, dat hopelijk snel komt.
  7. Nurfer 14 maart 2025 10:02

    • Nurfer

      Lid sinds: 21 nov 2015

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 32

      Gegeven: 0

    •    Aantal posts: 102

    Niet te geloven ... enkele procenten in de plus ... is dit de ommekeer op weg naar hogere koersen?
  9. aloha28 14 maart 2025 12:23

    • aloha28

      Lid sinds: 30 dec 2005

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 147

      Gegeven: 7

    •    Aantal posts: 752

    quote:

    Buffalo Bill schreef op 14 maart 2025 10:33:

    Dat moet je nooit te vroeg roepen Nurfer, want vanmiddag krijg je de deksel weer op de neus.
    Wacht maar af.
    met Onward krijg je bijna elke dag de deksel op je neus.
    een keer meer of minder maakt niets meer uit.
    ik blijf zitten en wacht op overname. Ik ben geen dag zonder
    Onward, FOMO

    succes allen
  11. Cybertom 14 maart 2025 12:32

    • Cybertom

      Lid sinds: 02 jul 2003

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 2075

      Gegeven: 292

    •    Aantal posts: 3.774

    Ook ik blijf zitten, sterker nog, ik blijf zelfs bijkopen zolang ik kan en het verantwoord vind. Deze koers slaat als een l.l op een drumstel.
  12. forum rang 4 nb 14 maart 2025 18:02

    • nb

      Lid sinds: 09 sep 2009

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 641

      Gegeven: 144

    •    Aantal posts: 3.797

    quote:

    Cybertom schreef op 13 maart 2025 15:30:

    Daar ga ik ook vanuit, derhalve nogmaals 2,5k bijgekocht op € 4,77
    Vooralsnog goed gedaan, man. Hoop dat we vanaf hier verder klimmen
  13. Cybertom 16 maart 2025 11:01

    • Cybertom

      Lid sinds: 02 jul 2003

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 2075

      Gegeven: 292

    •    Aantal posts: 3.774

    Hele interessante kost voor de echte beleggers, een transcript van de J.P. Morgan conference van afgelopenjanuari. Als je dit leest weet je weer waarom je deze aandelen beslist moet hebben.
    Bijlage:
  14. Renno54 16 maart 2025 15:39

    • Renno54

      Lid sinds: 14 feb 2014

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 106

      Gegeven: 1227

    •    Aantal posts: 213

    Er schijnt ook een artikel in de Chicago tribune te hebben gestaan, heb gezocht maar is niet gelukt om te achterhalen.??
  16. gyzmoo 16 maart 2025 21:05

    • gyzmoo

      Lid sinds: 21 feb 2022

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 24

      Gegeven: 5

    •    Aantal posts: 48

    With electrodes stuck to different parts of his back along his spine, Shane Callahan practiced walking on a recent day — with help from an exercise specialist and a harness that helped hold him upright.
    Callahan has a spinal cord injury, so he wasn’t supporting all of his own weight or moving his legs by himself. But something had changed. He had a little bit of sensation in his feet.
    “It’s pretty strange,” said Callahan, 22, of Lockport, who was injured as a passenger in a car accident 1 1/2 years ago. Since he started using the device with the electrodes, he said, he can feel his feet touching surfaces, though they still can’t feel pain or temperature. “I think there’s definitely noticeable progress.”
    The device, called the ARC-EX, delivers electrical pulses to his spine during his sessions at Next Steps Chicago, a neurological rehabilitation clinic in Willow Springs. The device was approved by the U.S. Food and Drug Administration in December, with some experts hailing it as a milestone in therapy for people with spinal cord injuries. Next Steps is one of the first two clinics in the country offering it.
    “It’s pretty miraculous,” said Mary Jones, a physical therapist and director of operations at Next Steps Chicago. “I spent my career working toward this and to see it come to fruition is nothing short of amazing.”
    Now, during Callahan’s appointments at Next Steps, neuro-adaptive exercise specialist Creighton Goss attaches electrodes to the back of Callahan’s neck along his cervical spine and then midway down his back, near his thoracic spine. Thin electrical cables connect the electrodes to the ARC-EX device, which delivers continuous electrical pulses throughout Callahan’s appointment.
    The stimulation doesn’t hurt, but “It definitely wakes you up,” Callahan said with a smile.
    The ARC-EX is not the first device to deliver electrical stimulation through the skin to help people with spinal cord injuries. But unlike other commercially available devices, the ARC-EX delivers stimulation directly to the spine, rather than to other parts of the body that a person wishes to move, such as to an arm or a leg. The idea is to restore hand strength and sensation even when stimulation is no longer used.
    The device is supposed to be used for up to an hour a day, alongside therapy or training, to help improve hand strength and sensation for people with incomplete spinal cord injuries. About two-thirds of people with spinal cord injuries in the U.S. have incomplete injuries, meaning that though their movement may be extremely limited, their spinal cords have not completely lost the ability to transmit messages to and from the brain.
    “Some instruction from the brain gets through but not enough to create a movement, so we’re providing an amplification of that signal from the brain,” said Dave Marver, CEO of Onward Medical, the company that sells the device.

    Dr. Arun Jayaraman, executive director of the Technology & Innovation Hub at Chicago rehabilitation hospital Shirley Ryan AbilityLab, who is not involved with Next Steps, called the device “an additional tool” that can be used to improve spinal cord signals to the limbs. He said it’s the first device of its kind to be FDA-approved and available for everyday use by clinicians, rather than just for research purposes. The AbilityLab has an agreement to use the device for its research studies in stroke and other medical conditions later this year.
    The device’s FDA approval is “huge” for the spinal cord injury community, said Marco Baptista, chief scientific officer with the Christopher and Dana Reeve Foundation, which helped support the device’s development with an investment in Onward. Philanthropic venture fund SCI Ventures, which was co-founded by the foundation and other nonprofits, now holds that investment, and any revenue received from the investment will go toward supporting more research, Baptista said.
    “One, this can be a device that can help people, and, two, it provides this path forward that other therapies can then follow,” Baptista said.
    Next Steps Chicago, a standalone nonprofit, helped test an earlier version of the device and has always felt it’s important to bring cutting-edge technologies into the community, Jones said.
    “This is a catastrophic lifelong condition,” Jones said of spinal cord injuries. “To make somebody’s life a little bit easier, to give them 10% improvement, that’s a big deal for someone who hasn’t moved their arm or is dependent on someone else for round-the-clock care.”
    The device costs clinics about $40,000, Marver said — not a small price tag, but also not the most expensive piece of equipment a clinic like Next Steps uses.
    In a study funded by Onward and published in May in the peer-reviewed journal Nature Medicine, 72% of participants saw improved strength and function in their hands and arms after using the device. The FDA specifically approved the device to be used to improve hand sensation and strength.

    Improving hand function is a priority for many people with spinal cord injuries, Marver said, sometimes even more so than regaining the ability to walk.
    “They need their hands to get through activities of daily living, to feed themselves, to clothe themselves, to go to the bathroom,” Marver said. “These are all things that introduce independence, dignity, quality of life.”
    The device doesn’t work for everyone, but so far Next Steps has seen about a dozen patients have positive results, including Callahan, Jones said. Though Callahan still has hand function, the device has helped with other areas of his body, Jones said.
    Callahan said he’d been a patient at Next Steps for about a year when Jones asked him if he wanted to try the ARC-EX device.
    “She was explaining the research behind it and the possible benefits of using it, and it seemed it was applicable to my injury, so I thought why not,” Callahan said.
    Callahan uses a wheelchair and is paralyzed from the diaphragm down. After his accident, he spent about two months as an inpatient at AbilityLab and then another six months doing outpatient rehab with the AbilityLab.
    Now, he goes to Next Steps about three times a week, for two hours at a time, where he practices movement in the treatment gym. At a recent appointment, Goss had him kneel in front of a low table, which he used to brace himself, using his arms. Goss then slowly helped Callahan move his legs back and forth, an exercise designed to help him practice shifting weight from one leg to the other.
    Callahan isn’t sure how much strength, movement or sensation he’ll ever regain. Everyone and every injury is different. “Nothing is guaranteed,” Callahan said, but he’s trying to recover as much as he can.
    “It would definitely improve my quality of life, not just for me, but for my family,” Callahan said of the prospect of regaining more function.
    “We’re hoping you walk in one day and say, ‘Peace out, I’m done,’” Goss said. “That would be the goal.”
    “That would be the goal,” Callahan agreed.
  18. forum rang 5 K. Wiebes 17 maart 2025 09:44

    • K. Wiebes

      Lid sinds: 13 sep 2007

      Laatste bezoek: 19 mrt 2025

    • Aanbevelingen

      Ontvangen: 1693

      Gegeven: 128

    •    Aantal posts: 5.648

    À propos plaatsen: Wanneer de IM-elektroden bij thuisgebruik langs de wervelkolom moeten
    worden geplaatst, zul je toch met z'n tweetjes moeten zijn: anders is 't nauwelijks te doen;
    zelfs wanneer je handen en armen góed werken.
838 Posts
Pagina: «« 1 ... 37 38 39 40 41 42 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.103
AB InBev 2 5.531
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.021
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.825
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.796
Aedifica 3 925
Aegon 3.258 323.027
AFC Ajax 538 7.088
Affimed NV 2 6.303
ageas 5.844 109.900
Agfa-Gevaert 14 2.062
Ahold 3.538 74.345
Air France - KLM 1.025 35.259
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.049
Alfen 16 25.141
Allfunds Group 4 1.516
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 417
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.701
AMG 971 134.186
AMS 3 73
Amsterdam Commodities 305 6.743
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 492
Antonov 22.632 153.605
Aperam 92 15.042
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.789
Arcelor Mittal 2.034 320.926
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.349
Aroundtown SA 1 221
Arrowhead Research 5 9.750
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.580
ASML 1.766 109.709
ASR Nederland 21 4.507
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.813
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.441

Macro & Bedrijfsagenda

  1. 20 maart

    1. Envipco Q4-cijfers
    2. Werkloosheid februari (NL)
    3. RWE Q4-cijfers (Dld)
    4. Producentenprijzen februari (Dld)
    5. Werkloosheid januari (VK)
    6. Bank of England rentebesluit (VK) volitaliteit verwacht
    7. Steunaanvragen wekelijks (VS)
    8. Philadelphia Fed index maart (VS)
    9. Bestaande woningverkopen (VS)
    10. Leidende indicatoren februari (VS)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht
Naar de hele agenda